SPPI News and Press, Spectrum Pharmaceuticals Inc. From 03/16/21

Spectrum Pharmaceuticals ([[SPPI]] -3.0%) has announced that the FDA has scheduled the pre-approval inspection at the ROLONTIS (eflapegrastim) manufacturing site for May 2021.“We believe the pre-approval inspection marks the final step in the ROLONTIS review process,” ...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has scheduled the pre-approval inspection at the ROLONTIS® (eflapegrastim) manufacturing site in...

Nova LifeStyle (NVFY) +231%.Siebert Financial (SIEB) +63% on Q4 results.Vir Biotechnology (VIR) +60% as its and GSK's COVID-19 antibody drug reduces hospitalization, death by 85%.OrganiGram Holdings (OGI) +40% on cannabis product deal with British American Tobacco.China HGS Rea...

Spectrum Pharmaceuticals (SPPI) announces that the U.S. FDA has granted Fast Track designation for poziotinib for the treatment of non-small cell lung cancer ((NSCLC)) in previously treated patients with HER2 exon 20 mutations.Shares of the company jump nearly 26% premarket.Spectrum...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for poziotinib for the treatment of non-small cell lung cancer (NS...

Today, we take an in-depth look at Spectrum Pharmaceuticals for the first time. This small developmental concern is based just outside of Las Vegas. The company saw some recent challenges with its pipeline. Our assessment of this $3.50 battleground stock among analysts follow...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dosing safety and efficacy data for poziotinib from Cohort 5 of the ZENITH20 clinical trial. These...

Biotech Penny Stocks To Watch Right Now February closed out with a tumultuous week of trading in more than just penny stocks . Fears of inflation and uncertainty about the final stimulus plan triggered large sell-offs last week. Whether you were looking at small-caps or broader sect...

Gainers: [[SIOX]] +12.1%. [[OPTN]] +7.2%. [[BDSI]] +5.7%. [[SSP]] +4.9%. [[SPPI]] +4.9%.Losers: [[PCTI]] -6.5%. [[SVC]] -5.4%. [[GNFT]] -4.2%. [[NIU]] -3.4% [[CATB]] -2%. For further details see: NIU, SPPI, BDSI and SVC among after-hours movers

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation on interim safety evaluation of same-day dosing of ROLONTIS ® (eflapegrastim) in patients with early-stage breast cance...